1 active not recruiting, 1 completed, 1 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Charcoal: new trials by email Literature Review of Charcoal trials Research Report on Charcoal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis Frexalimab, Teriflunomide, Placebo infusion - Multiple Sclerosis | Phase 3 | Active not recruiting | Sanofi | 1655 | 2023-12-13 | 2026-07-20 |
| Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney Disease Activated Charcoal, Probiotic, No intervention - Uremic Toxin | Phase 2 / Phase 3 | Unknown | Waleed Khaild Rahman Kareem Al-kabi | 60 | 2022-09-25 | 2022-09-14 |
| Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis teriflunomide HMR1726, cholestyramine, charcoal - Multiple Sclerosis | Phase 3 | Completed | Sanofi | 70 | 2013-10-01 | 2015-03-13 |
Sanofi (2) · Waleed Khaild Rahman Kareem Al-kabi (1)
Belgium (2) · Germany (2) · Argentina (1) · Austria (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · China (1) · Croatia (1) · Czechia (1) · Denmark (1) · France (1) · Greece (1) · Hong Kong (1)
2023 (1)